COMMUNIQUÉS West-GlobeNewswire

Sienna Biopharmaceuticals Appoints Caroline Van Hove as Chief Commercial Officer
22/03/2018
WESTLAKE VILLAGE, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced the appointment of Caroline Van Hove as the Company’s first Chief Commercial Officer. Ms. Van [...]
Avid Bioservices Receives Six 2018 CMO Leadership Awards
22/03/2018
TUSTIN, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
2017 Annual Report - DTR 6.3.5 and LR 9.6.1 Disclosures
22/03/2018
2017 Annual Report - DTR 6.3.5 and LR 9.6.1 Disclosures March 22, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that the following documents will today be posted to shareholders: > 2017 Annual [...]
Achaogen Announces New Employment Inducement Grants
22/03/2018
SOUTH SAN FRANCISCO, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]
Vital Therapies Announces VTL-308 Reaches Enrollment Target of 150 Subjects
22/03/2018
SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today [...]
Todos Medical reports on results of clinical trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, Israel
22/03/2018
REHOVOT, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) ( http://www.Todosmedical.com ) today announced the results of a clinical trial recently completed at Kaplan Hospital in Rehovot, [...]
Spero Therapeutics to Present at Upcoming Investor Conferences
22/03/2018
CAMBRIDGE, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]
Envigo to Expand Livermore, California Research Model Surgical Facility to Meet Rising Demand from West Coast Biopharmaceutical Companies
22/03/2018
East Millstone, N.J., March 22, 2018 (GLOBE NEWSWIRE) -- Envigo, a leading provider of nonclinical contract research services and research models, is investing in an expansion of its research model surgical facility at [...]
Progressive Care Releases Audited 2017 Annual Report
22/03/2018
MIAMI, March 22, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces 2017 annual results. The Company announced over $20 million in net revenues, a 10% [...]
Zealand Pharma convenes its Annual General Meeting 2018
22/03/2018
Company Announcement - No. 10/2018 Zealand Pharma convenes its Annual General Meeting 2018 Copenhagen, March 22, 2018 - Zealand Pharma A/S ("Zealand") convenes the Company's ordinary Annual General Meeting to be held on [...]
Precipio Restructures Capitalization Table
22/03/2018
NEW HAVEN, Conn., March 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), in an 8-K issued today announced an agreement with investors in certain 2017 underwritten and registered [...]
Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer
22/03/2018
DUBLIN, Ireland, March 22, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ), “Avadel” or the “Company,” today announced the promotion of Gregory J. Divis to Executive Vice President and Chief [...]
Reata Announces Positive Top-Line Data for Treatment of PH-ILD With Bardoxolone Methyl From the Phase 2 Lariat Trial
22/03/2018
Significant Improvement in 6MWD in Patients With IPF and Sarcoidosis No Safety Signals Identified IRVING, Texas, March 22, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a [...]
Helix BioPharma Corp Welcomes Drs. Daniel Von Hoff, Kazimierz Roszkowski-Sliz and Robert Gillies to Its Scientific and Strategic Advisory Board
22/03/2018
RICHMOND HILL, Ontario, March 22, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Young Doctors Warned of Pitfalls in Employment Contracts, in Journal of American Physicians and Surgeons (AAPS)
22/03/2018
TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Physicians just out of residency, experiencing their first taste of independence, need to beware of traps in employment contracts, writes Philip Eskew , D.O., J.D., M.B. [...]
Aino Health AB (publ): Aino Health AB signs contract with Multi Contact GmbH
22/03/2018
The German company Multi Contact, which is part of the Otto Group, has signed a contract with Aino Health regarding use of the IT platform HealthManager to improve Multi Contact's own health management. The deal also [...]
Notice to Convene Annual General Meeting 2018
22/03/2018
Company Announcement no. 05/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 22 March 2018 Notice to Convene Annual General Meeting 2018 The board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 (" [...]
CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody
22/03/2018
SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
CORRECTION: Recording of the Fourth Quarter 2017 Investor Conference Webinar (Presentation added)
22/03/2018
Olaine, 2018-03-22 12:10 CET (GLOBE NEWSWIRE) -- The recorded AS “Olainfarm” webinar is available online: http://ej.uz/OLF_Q4_2017 , and the presentation, demonstrated during the webinar, is available in the attachment [...]

Pages